id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-4212-0009,FDA,FDA-2019-D-4212,Wholesale Distributor Verification Requirement for Saleable Returned Drug Product and Dispenser Verification Requirements When Investigating a Suspect or Illegitimate Product—Compliance Policies Guidance for Industry,Other,Guidance,2023-09-01T04:00:00Z,2023,9,2023-09-01T04:00:00Z,,2024-11-12T23:54:10Z,,1,0,0900006485f31af3
FDA-2019-D-4212-0008,FDA,FDA-2019-D-4212,"Wholesale Distributor Verification Requirement for Saleable Returned Drug Product and Dispenser Verification Requirements When Investigating a Suspect or Illegitimate Product—Compliance Policies, Revision 1; Guidance for Industry; Availability",Rule,Final Rule,2023-09-01T04:00:00Z,2023,9,2023-09-01T04:00:00Z,,2023-09-05T13:17:12Z,2023-18899,0,0,0900006485f2ff32